Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Closed to new applicants - Letter of Intent deadline passed September 15, 2026Atlas Opportunity Score 72/100
OHSU BIP Device, Diagnostic & Software 2027Oregon

Oregon OHSU Biomedical Innovation Program Device, Diagnostic & Software 2027

FundingUp to $40,000 per competitive project
DeadlineSeptember 15, 2026; exact closing time and time zone not stated in the controlling RFA
Last verifiedSeptember 18, 2026
Required next actionDo not begin new applicant outreach for the 2027 Device, Diagnostic & Software cycle because the September 15, 2026 Letter of Intent deadline has passed. Continue package support only for an already-qualified OHSU applicant that timely submitted an LOI and is advancing to the October 26 full-application stage.

Broad Eligibility

Open to OHSU employees and students; human-subject or animal projects require OHSU PI eligibility and applicable approvals; non-faculty applicants require written supervisor or department-head approval authorizing effort.

Atlas Analysis

Atlas Opportunity Score 72/100. N9+ Fit Score 5/100. Strong healthcare-innovation funding but not a direct Dr. Miltie/N9+ opportunity because applicants must be OHSU employees or students and projects must be legitimate OHSU-led novel technologies.

Opportunity Overview

Oregon Health & Science University is accepting letters of intent for the Biomedical Innovation Program (BIP) Device, Diagnostic & Software 2027 cycle. The program supports development and commercialization of novel technologies intended to improve healthcare delivery, with project-management and commercialization mentorship for awardees.

Funding and Timeline

Competitive project budgets are available up to $40,000, and projects are typically expected to run for about 12 months. Letters of intent are due September 15, 2026. The controlling RFA does not state an exact LOI closing time or time zone. Selected projects are invited to a five-page full application due October 26, 2026, followed by Q&A on November 12 and final presentations on December 10.

Eligibility and Application Requirements

The 2027 RFA states that the program is open to OHSU employees and students. Applicants must submit a Technology Disclosure Form, use the required LOI template, and submit through REDCap. The LOI is limited to two pages and may include up to two letters of support. Human-subject or animal projects require applicants to meet OHSU Principal Investigator requirements and obtain applicable approvals before funding release. Non-faculty applicants need written supervisor or department-head approval authorizing the proposed effort.

N9+ / QC Strategic Analysis

Atlas Opportunity Score: 72/100. N9+ Fit Score: 5/100. The program is highly relevant to healthcare innovation generally, but it funds OHSU employee/student-led novel technologies. The existing external Nonagon N9+ remote physical examination platform is not itself an eligible applicant project absent a legitimate OHSU-led new invention or development effort. Dr. Miltie is not a direct applicant.

Next Action

Track for a legitimate OHSU employee or student-led device, diagnostic, or software project. Before any package support, verify Technology Disclosure status, applicant eligibility, supervisor approval where required, PI status for regulated research, project budget, letters of support, and REDCap submission requirements.

Source verificationReferenced source · www.ohsu.eduAtlas last verified this record September 18, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗